CHIRAG PATEL: Open Payments
NPI 1205981750 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 9 payments from 5 companies in 2025. Trend: 2023 $537 · 2024 $335 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $118 |
| ABBVIE INC. | 2 | $36 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| Lilly USA, LLC | 1 | $20 |
Products named: REXULTI, LUMRYZ, QULIPTA, IQIRVO, AMYVID.
Industry payments across IN — which companies pay providers there.
